{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:59:16Z","timestamp":1795121956378,"version":"4.10.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64839-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:53:49Z","timestamp":1763704429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cancer cell-derived IL-1\u03b2 reverses chemo-immunotherapy resistance in non-small cell lung cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Ana\u00efs","family":"Perrichet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lecuelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeric","family":"Limagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Thiefin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bellio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-3287","authenticated-orcid":false,"given":"Romain","family":"Aucagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Aznague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Gaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-6827","authenticated-orcid":false,"given":"Nicolas","family":"Roussot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9439-9027","authenticated-orcid":false,"given":"Thibault","family":"Vernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Nuttin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alis","family":"Ilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rageot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Derang\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titouan","family":"Huppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-8178","authenticated-orcid":false,"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-9149","authenticated-orcid":false,"given":"Bertrand","family":"Routy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Truntzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chalmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-8305","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Ghiringhelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8831-145X","authenticated-orcid":false,"given":"C\u00e9dric","family":"R\u00e9b\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"64839_CR1","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi, L. et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med. 378, 2078\u20132092 (2018).","journal-title":"N. Engl. J. Med."},{"key":"64839_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","volume":"616","author":"W Hill","year":"2023","unstructured":"Hill, W. et al. Lung adenocarcinoma promotion by air pollutants. Nature 616, 159\u2013167 (2023).","journal-title":"Nature"},{"key":"64839_CR3","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3390\/cells11223672","volume":"11","author":"N Roussot","year":"2022","unstructured":"Roussot, N., Ghiringhelli, F. & R\u00e9b\u00e9, C. Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment. Cells 11, 3672 (2022).","journal-title":"Cells"},{"key":"64839_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/imr.13263","volume":"321","author":"F Ghiringhelli","year":"2024","unstructured":"Ghiringhelli, F. & R\u00e9b\u00e9, C. Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application. Immunological Rev. 321, 335\u2013349 (2024).","journal-title":"Immunological Rev."},{"key":"64839_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/imt-2018-0193","volume":"11","author":"AM Frederickson","year":"2019","unstructured":"Frederickson, A. M. et al. Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysis. Immunotherapy 11, 407\u2013428 (2019).","journal-title":"Immunotherapy"},{"key":"64839_CR6","doi-asserted-by":"publisher","first-page":"E1791","DOI":"10.3390\/cancers12071791","volume":"12","author":"C R\u00e9b\u00e9","year":"2020","unstructured":"R\u00e9b\u00e9, C. & Ghiringhelli, F. Interleukin-1\u03b2 and Cancer. Cancers 12, E1791 (2020).","journal-title":"Cancers"},{"key":"64839_CR7","doi-asserted-by":"publisher","first-page":"E3550","DOI":"10.3390\/cancers12123550","volume":"12","author":"A Perrichet","year":"2020","unstructured":"Perrichet, A., Ghiringhelli, F. & R\u00e9b\u00e9, C. Understanding inflammasomes and PD-1\/PD-L1 crosstalk to improve cancer treatment efficiency. Cancers 12, E3550 (2020).","journal-title":"Cancers"},{"key":"64839_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/0008-5472.CAN-06-2956","volume":"67","author":"Y Krelin","year":"2007","unstructured":"Krelin, Y. et al. Interleukin-1\u03b2\u2013driven inflammation promotes the development and invasiveness of chemical carcinogen\u2013induced tumors. Cancer Res. 67, 1062\u20131071 (2007).","journal-title":"Cancer Res."},{"key":"64839_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.169.1.469","volume":"169","author":"Y Saijo","year":"2002","unstructured":"Saijo, Y. et al. Proinflammatory cytokine IL-1\u03b2 promotes tumor growth of Lewis Lung Carcinoma by induction of angiogenic factors: In vivo analysis of tumor-stromal interaction. J. Immunol. 169, 469\u2013475 (2002).","journal-title":"J. Immunol."},{"key":"64839_CR10","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S Nakao","year":"2005","unstructured":"Nakao, S. et al. Infiltration of COX-2\u2013expressing macrophages is a prerequisite for IL-1\u03b2\u2013induced neovascularization and tumor growth. J. Clin. Invest. 115, 2979\u20132991 (2005).","journal-title":"J. Clin. Invest."},{"key":"64839_CR11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41388-019-1099-5","volume":"39","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. Targeting the IL-1\u03b2\/EHD1\/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC. Oncogene 39, 1739\u20131755 (2020).","journal-title":"Oncogene"},{"key":"64839_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1158\/2326-6066.CIR-19-0552","volume":"8","author":"T Tian","year":"2020","unstructured":"Tian, T. et al. IL1\u03b1 Antagonizes IL1\u03b2 and promotes adaptive immune rejection of malignant tumors. Cancer Immunol. Res 8, 660\u2013671 (2020).","journal-title":"Cancer Immunol. Res"},{"key":"64839_CR13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"64839_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1200\/JCO.23.00980","volume":"42","author":"DSW Tan","year":"2024","unstructured":"Tan, D. S. W. et al. Canakinumab versus placebo in combination with first-line pembrolizumab plus chemotherapy for advanced non\u2013small-cell lung cancer: Results From the CANOPY-1 Trial. JCO 42, 192\u2013204 (2024).","journal-title":"JCO"},{"key":"64839_CR15","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.lungcan.2023.107451","volume":"189","author":"L Paz-Ares","year":"2024","unstructured":"Paz-Ares, L. et al. Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial. Lung Cancer 189, 107451 (2024).","journal-title":"Lung Cancer"},{"key":"64839_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/JCO.23.00910","volume":"42","author":"EB Garon","year":"2024","unstructured":"Garon, E. B. et al. Canakinumab as adjuvant therapy in patients with completely resected non\u2013small-cell lung cancer: Results from the CANOPY-A double-blind, randomized clinical trial. JCO 42, 180\u2013191 (2024).","journal-title":"JCO"},{"key":"64839_CR17","doi-asserted-by":"publisher","first-page":"S1547","DOI":"10.1016\/j.annonc.2022.10.322","volume":"33","author":"TSK Mok","year":"2022","unstructured":"Mok, T. S. K. et al. LBA4 CANOPY-N: A phase II study of canakinumab (CAN) or pembrolizumab (PEM), alone or in combination, as neoadjuvant therapy in patients (pts) with resectable stage Ib\u2013IIIa non-small cell lung cancer (NSCLC). Ann. Oncol. 33, S1547\u2013S1548 (2022).","journal-title":"Ann. Oncol."},{"key":"64839_CR18","doi-asserted-by":"publisher","first-page":"e004241","DOI":"10.1136\/jitc-2021-004241","volume":"10","author":"J Lecuelle","year":"2022","unstructured":"Lecuelle, J. et al. MER4 endogenous retrovirus correlated with better efficacy of anti-PD1\/PD-L1 therapy in non-small cell lung cancer. J. Immunother. Cancer 10, e004241 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"64839_CR19","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers, M. et al. IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade. J. Clin. Invest. 127, 2930\u20132940 (2017).","journal-title":"J. Clin. Invest."},{"key":"64839_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.immuni.2019.08.005","volume":"51","author":"CL Evavold","year":"2019","unstructured":"Evavold, C. L. & Kagan, J. C. Inflammasomes: Threat-assessment organelles of the innate immune system. Immunity 51, 609\u2013624 (2019).","journal-title":"Immunity"},{"key":"64839_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.cell.2017.09.029","volume":"171","author":"EV Dang","year":"2017","unstructured":"Dang, E. V., McDonald, J. G., Russell, D. W. & Cyster, J. G. Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation. Cell 171, 1057\u20131071.e11 (2017).","journal-title":"Cell"},{"key":"64839_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","volume":"165","author":"VAK Rathinam","year":"2016","unstructured":"Rathinam, V. A. K. & Fitzgerald, K. A. Inflammasome complexes: Emerging mechanisms and effector functions. Cell 165, 792\u2013800 (2016).","journal-title":"Cell"},{"key":"64839_CR23","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1016\/j.cell.2021.09.034","volume":"184","author":"KN Miller","year":"2021","unstructured":"Miller, K. N. et al. Cytoplasmic DNA: sources, sensing, and role in aging and disease. Cell 184, 5506\u20135526 (2021).","journal-title":"Cell"},{"key":"64839_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao6047","volume":"359","author":"K McArthur","year":"2018","unstructured":"McArthur, K. et al. BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359, eaao6047 (2018).","journal-title":"Science"},{"key":"64839_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"E-H Choi","year":"2023","unstructured":"Choi, E.-H. & Park, S.-J. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target. Exp. Mol. Med. 55, 1348\u20131356 (2023).","journal-title":"Exp. Mol. Med."},{"key":"64839_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2015.08.008","volume":"43","author":"DN Bronner","year":"2015","unstructured":"Bronner, D. N. et al. Endoplasmic reticulum stress activates the inflammasome via NLRP3- and Caspase-2-driven mitochondrial damage. Immunity 43, 451\u2013462 (2015).","journal-title":"Immunity"},{"key":"64839_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/2159-8290.CD-20-0812","volume":"11","author":"SS Gu","year":"2021","unstructured":"Gu, S. S. et al. Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade. Cancer Discov. 11, 1524\u20131541 (2021).","journal-title":"Cancer Discov."},{"key":"64839_CR28","doi-asserted-by":"crossref","unstructured":"Limagne, E. et al. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell 40, 136\u2013152 (2022).","DOI":"10.1016\/j.ccell.2021.12.009"},{"key":"64839_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401\u2013414 (2012).","journal-title":"Immunity"},{"key":"64839_CR30","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. Dual effect of tryptamine on prostate cancer cell growth regulation: A pilot study. Int. J. Mol. Sci.23, 11087 (2022).","DOI":"10.3390\/ijms231911087"},{"key":"64839_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41416-022-01893-5","volume":"127","author":"MP Lythgoe","year":"2022","unstructured":"Lythgoe, M. P. & Prasad, V. Repositioning canakinumab for non-small cell lung cancer\u2014important lessons for drug repurposing in oncology. Br. J. Cancer 127, 785\u2013787 (2022).","journal-title":"Br. J. Cancer"},{"key":"64839_CR32","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1038\/s41388-020-1176-9","volume":"39","author":"M Qi","year":"2020","unstructured":"Qi, M. et al. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics. Oncogene 39, 2707\u20132723 (2020).","journal-title":"Oncogene"},{"key":"64839_CR33","doi-asserted-by":"publisher","first-page":"20161","DOI":"10.1002\/jcp.28617","volume":"234","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway. J. Cell. Physiol. 234, 20161\u201320173 (2019).","journal-title":"J. Cell. Physiol."},{"key":"64839_CR34","doi-asserted-by":"publisher","unstructured":"Qin, Y. et al. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. Front. Immunol.13, https:\/\/doi.org\/10.3389\/fimmu.2022.998266 (2022).","DOI":"10.3389\/fimmu.2022.998266"},{"key":"64839_CR35","doi-asserted-by":"publisher","unstructured":"Bodnar-Wachtel, M. et al. Inflammasome-independent NLRP3 function enforces ATM activity in response to genotoxic stress. Life Sci. Alliance6, https:\/\/doi.org\/10.26508\/lsa.202201494 (2023).","DOI":"10.26508\/lsa.202201494"},{"key":"64839_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/db10-0266","volume":"60","author":"TB Koenen","year":"2011","unstructured":"Koenen, T. B. et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1\u03b2 transcription in human adipose tissue. Diabetes 60, 517\u2013524 (2011).","journal-title":"Diabetes"},{"key":"64839_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn0327","volume":"386","author":"MD Park","year":"2024","unstructured":"Park, M. D. et al. Hematopoietic aging promotes cancer by fueling IL-1\u03b1\u2013driven emergency myelopoiesis. Science 386, eadn0327 (2024).","journal-title":"Science"},{"key":"64839_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni, N. et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623, 415\u2013422 (2023).","journal-title":"Nature"},{"key":"64839_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80\u201384 (2014).","journal-title":"Science"},{"key":"64839_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41277-z","volume":"9","author":"BW Stringer","year":"2019","unstructured":"Stringer, B. W. et al. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. Sci. Rep. 9, 4902 (2019).","journal-title":"Sci. Rep."},{"key":"64839_CR41","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/sj.onc.1209218","volume":"25","author":"Z Wang","year":"2006","unstructured":"Wang, Z. et al. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 25, 1903\u20131913 (2006).","journal-title":"Oncogene"},{"key":"64839_CR42","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.4049\/jimmunol.159.5.2452","volume":"159","author":"M Labow","year":"1997","unstructured":"Labow, M. et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159, 2452\u20132461 (1997).","journal-title":"J. Immunol."},{"key":"64839_CR43","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.187.9.1463","volume":"187","author":"R Horai","year":"1998","unstructured":"Horai, R. et al. Production of mice deficient in genes for interleukin (IL)-1\u03b1, IL-1\u03b2, IL-1\u03b1\/\u03b2, and IL-1 receptor antagonist shows that IL-1\u03b2 is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463\u20131475 (1998).","journal-title":"J. Exp. Med."},{"key":"64839_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"64839_CR45","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"64839_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"64839_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"64839_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"64839_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"64839_CR50","doi-asserted-by":"crossref","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics29, 15\u201321 (2013).","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"64839_CR51","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"64839_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"64839_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0167-9473(02)00225-6","volume":"43","author":"T Hothorn","year":"2003","unstructured":"Hothorn, T. & Lausen, B. On the exact distribution of maximally selected rank statistics. Comput. Stat. Data Anal. 43, 121\u2013137 (2003).","journal-title":"Comput. Stat. Data Anal."},{"key":"64839_CR54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 (2018).","journal-title":"Cell"},{"key":"64839_CR55","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64839_CR56","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. 060012 Preprint at https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64839-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:02:36Z","timestamp":1763733756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64839-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64839"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64839-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10244"}}